UAG
AZN icon

United Advisor Group’s AstraZeneca AZN Stock Holding History

United Advisor Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$222K Buy
+1,127
New +$217K 0.03% 469

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

United Advisor Group's AZN Position: Q1 2026 in Review

United Advisor Group opened a new position in AstraZeneca (AZN) in Q1 2026: 1,127 shares worth $222K. The stake represents 0.03% of the portfolio and ranks #469 among its holdings.

1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • United Advisor Group held 1,127 shares of AstraZeneca worth $222K as of Q1 2026.
  • AstraZeneca was a new United Advisor Group position in Q1 2026.
  • AstraZeneca made up 0.03% of United Advisor Group's portfolio in Q1 2026, its #469 holding.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on United Advisor Group's 13F filing for Q1 2026, filed 17 Apr 2026.